BEDFORD, Mass. (AP) _ Homology Medicines Inc. (FIXX) on Tuesday reported a loss of $19 million in its fourth quarter.
The Bedford, Massachusetts-based company said it had a loss of 51 cents per share.
The gene editing company posted revenue of $980,000 in the period.
For the year, the company reported a loss of $57.2 million, or $2 per share. Revenue was reported as $3.7 million.
Homology Medicines shares have increased 22 percent since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX